scholarly article | Q13442814 |
P50 | author | David S Knopman | Q63967707 |
P2093 | author name string | H M Kim | |
P S Appelbaum | |||
S Y H Kim | |||
J H T Karlawish | |||
K M Langa | |||
P2860 | cites work | Alzheimer Disease in the US Population | Q22253055 |
Are racial and ethnic minorities less willing to participate in health research? | Q24814743 | ||
Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization | Q28185520 | ||
The accuracy of surrogate decision makers: a systematic review | Q33236318 | ||
Increasing ethnic minority participation in Alzheimer disease research | Q34915661 | ||
Protecting subjects with decisional impairment in research: the need for a multifaceted approach | Q35616213 | ||
Proxy and surrogate consent in geriatric neuropsychiatric research: update and recommendations | Q35762172 | ||
Willingness of minorities to participate in biomedical studies: confirmatory findings from a follow-up study using the Tuskegee Legacy Project Questionnaire. | Q36274185 | ||
The capacity to appoint a proxy and the possibility of concurrent proxy directives | Q43816511 | ||
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease | Q45883058 | ||
How strictly do dialysis patients want their advance directives followed? | Q45957679 | ||
Proxy consent to research: the legal landscape | Q46451499 | ||
What do people at risk for Alzheimer disease think about surrogate consent for research? | Q50121906 | ||
Medical decision-making capacity in patients with mild cognitive impairment. | Q51898496 | ||
Informed Consent for Alzheimer's Disease Clinical Trials: A Survey of Clinical Investigators | Q51948881 | ||
Impaired decision-making ability in subjects with Alzheimer's disease and willingness to participate in research. | Q51957389 | ||
Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research. | Q51967278 | ||
Assessing the competency of patients with Alzheimer's disease under different legal standards. A prototype instrument. | Q52013373 | ||
Demented subjects' competence to consent to participate in field studies: the Berlin Ageing Study. | Q53019301 | ||
Deliberating about Bioethics | Q53597498 | ||
Ability of family members to predict patient's consent to critical care research | Q56786206 | ||
Views of potential subjects toward proposed regulations for clinical research with adults unable to consent | Q77851730 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | informed consent | Q764527 |
dementia | Q83030 | ||
P304 | page(s) | 149-155 | |
P577 | publication date | 2009-01-01 | |
P1433 | published in | Neurology | Q1161692 |
P1476 | title | Surrogate consent for dementia research: a national survey of older Americans | |
P478 | volume | 72 |
Q38523616 | A review of ethical issues in dementia |
Q36848494 | Acceptable Approaches to Enrolling Adults Who Cannot Consent in More Than Minimal Risk Research |
Q49842947 | Advance directives as a tool to respect patients' values and preferences: discussion on the case of Alzheimer's disease |
Q42280517 | Assessing capacity to consent for research in cognitively impaired older patients. |
Q33786044 | Assessing the public's views in research ethics controversies: deliberative democracy and bioethics as natural allies |
Q38439734 | Comfort with proxy consent to research involving decisionally impaired older adults: do type of proxy and risk-benefit profile matter? |
Q37765204 | Consent in impaired populations |
Q33927499 | Deliberative assessment of surrogate consent in dementia research |
Q48757186 | Depression and QOL in patients with ALS: how do self-ratings and ratings by relatives differ? |
Q35606210 | Effect of public deliberation on attitudes toward surrogate consent for dementia research |
Q36473380 | Ethics in Psychiatric Research: A Review of 25 Years of NIH-funded Empirical Research Projects |
Q33618942 | How are the interests of incapacitated research participants protected through legislation? An Italian study on legal agency for dementia patients |
Q28485900 | How important is 'accuracy' of surrogate decision-making for research participation? |
Q39269360 | Informed Consent to Research with Cognitively Impaired Adults: Transdisciplinary Challenges and Opportunities. |
Q38866477 | Is Safety in the Eye of the Beholder? Safeguards in Research With Adults With Intellectual Disability. |
Q35911152 | Methodological challenges in physical activity research with older adults |
Q97526431 | Motivations for people with cognitive impairment to complete an advance research directive - a qualitative interview study |
Q35952203 | Preservation of the capacity to appoint a proxy decision maker: implications for dementia research |
Q91677710 | Procedural Framework to Facilitate Hospital-Based Informed Consent for Dementia Research |
Q34119662 | Promoting advance planning for health care and research among older adults: a randomized controlled trial |
Q35977251 | Public's approach to surrogate consent for dementia research: cautious pragmatism |
Q57554355 | Publicʼs Approach to Surrogate Consent for Dementia Research |
Q35170180 | Research involving subjects with Alzheimer's disease in Italy: the possible role of family members |
Q37612538 | Surrogate consent for research involving adults with impaired decision making: Survey of Institutional Review Board practices |
Q36003976 | Surrogate consent to non-beneficial research: erring on the right side when substituted judgments may be inaccurate |
Q82797891 | Surrogate decision making for patients with end-stage dementia |
Q34924092 | Temporal stability of receptiveness to clinical research on Alzheimer disease |
Q36330685 | The ethics of informed consent in Alzheimer disease research |
Q46180164 | Time to reinvent the science of dementia: the need for care and social integration |
Q34260794 | Using data to improve surrogate consent for clinical research with incapacitated adults |
Q34466166 | Why are spousal caregivers more prevalent than nonspousal caregivers as study partners in AD dementia clinical trials? |
Search more.